Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-754-0 | CAS number: 22047-49-0
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Study period:
- 24 Jul - 16 Aug 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study with acceptable restrictions. No data given about the reliability check.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- no data given on reliability check
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- not specified
Test material
- Reference substance name:
- Reference substance 001
- Cas Number:
- 135800-37-2
- Molecular formula:
- C16H32O2 to C26H52O2
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright white
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann Versuchstierzucht, Borchen, Germany
- Age at study initiation: approx. 5 weeks
- Diet: Altromin Haltungsdiät 3032 DK, Lage, Germany, ad libitum; with additive carrots
- Water: tap water with an additive of ascorbic acid (1 g/L), ad libitum
- Mean weight at study initiation: 415 g
- Housing: 2-3 animals in Makrolon type IV cages
- Acclimation period: 5 days
- date of delivery: July 19th, 1990
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-25
- Humidity (%): 45-70
- Photoperiod (hrs dark / hrs light): 12 / 12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- paraffin oil
- Concentration / amount:
- Preliminary study:
Intracutaneous induction: 0.5, 1 and 2%
Epicutaneous induction and retreatment: 40, 50, 60 and 70%
Main study:
Intracutaneous induction: 0.5%
Epicutaneous induction: 40%
Challenge: 20%
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- Preliminary study:
Intracutaneous induction: 0.5, 1 and 2%
Epicutaneous induction and retreatment: 40, 50, 60 and 70%
Main study:
Intracutaneous induction: 0.5%
Epicutaneous induction: 40%
Challenge: 20%
- No. of animals per dose:
- Preliminary study: 2 animals
Main study:
Test group: 20 females
Control group: 10 females - Details on study design:
- RANGE FINDING TESTS: Yes, evaluation of dermal effects was done by treating the animals with 0.5%, 1% or 2% for intracutaneous induction (injection of 0.1 mL into the shaved flank) and 40%, 50%, 60% or 70% for epicutaneous induction and retreatment of the test substance (0.08 g on the shaved flank) and observation of irritating effects 24 h and 48 h after treatment.
Intradermal: Minimal irritation at 0.5% of the test article
Dermal: Minimal irritation at 40%
Based on the results of the preliminary study the minimal irritating concentrations, 0.5% dilution of the test substance in paraffine oil was used for intradermal induction and 40% of the test substance was used for the epidermal induction exposure. A 20% test substance concentration was selected as maximally non-irritating for the challenge phase.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single application (intradermal induction on Day 1) and 48 hours (epidermal induction on Day 7)
- Test groups: 1
Intradermal (double injections):
Injection 1: 0.1 mL 1:1 mixture (v/v) Freuds'complete adjuvant (FCA) in paraffin oil
Injection 2: 0.1 mL test substance with vehicle (paraffin oil) in concentration minimally irritating (5%)
Injection 3: 0.1 mL test substance in a 1:1 mixture (v/v) with FCA (final concentrations: test substance minimally irritating (5%), FCA 50%)
Epicutaneous: test substance (40%) with vehicle (paraffin oil)
- Control group: 1
Intradermal (double injections; the injections 1 and 3 were identical):
Injection 1 and 3: a 1:1 mixture (v/v) FCA in paraffin oil
Injection 2: only vehicle (paraffin oil)
Epicutaneous: vehicle (paraffin oil)
- Site: symmetrically on both sides of the spine and from cranial to cauda
- Frequency of applications: once
- Concentrations: intradermal: 0.5%, epicutaneous: 40%
- Other: An examination of the injections was performed 1 and 24 hours after treatment.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Day 22 (14 days after induction)
- Exposure period: 24 h
- Test groups: test substance and vehicle (paraffin oil)
- Control group: test substance and vehicle (paraffin oil)
- Site: One sheared flank
- Concentrations: 20% solution in paraffin oil
- Evaluation (hrs after the end of the challenge exposure): 24 and 48 h
- Other: 24 hrs after challenge application the application area was washed off with warm water - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 20%
- No. with + reactions:
- 1
- Total no. in group:
- 19
- Clinical observations:
- One animal died after first induction
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 20% . No with. + reactions: 1.0. Total no. in groups: 19.0. Clinical observations: One animal died after first induction.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 20%
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Clinical observations:
- No
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 20%. No with. + reactions: 5.0. Total no. in groups: 10.0. Clinical observations: No.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 20%
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Clinical observations:
- One animal died after first induction
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 20%. No with. + reactions: 0.0. Total no. in groups: 19.0. Clinical observations: One animal died after first induction.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 20%
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- No
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 20%. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: No.
Any other information on results incl. tables
Main study:
Intracutaneous induction: After one hour, weak effects were observed in 7 of 20 treated animals and none of the control animals. 24 h after treatment, 11 of 20 treated animals showed weak effekts and again none of the control animals.
Epicutaneous induction: After one hour, weak up to moderate skin reactions were observed in 16 of 19 treated animals (one died after exposure) and in 7 of 10 control animals. 24 h later mostly weak effects were observed in 10 treated animals and in 2 of the control animals.
Challenge readings - grades of skin reaction of individual animals
Animal No. |
Intracut. induction |
Epicut. induction |
Challenge |
|||
1 h |
24 h |
1 h |
24 h |
24 h |
48 h |
|
Control Animals |
||||||
27 |
0 |
0 |
1 |
0 |
1 |
0 |
28 |
0 |
0 |
1 |
0 |
1 |
0 |
29 |
0 |
0 |
1 |
0 |
0 |
0 |
30 |
0 |
0 |
1 |
0 |
0 |
0 |
31 |
0 |
0 |
0 |
0 |
1 |
0 |
32 |
0 |
0 |
2 |
1 |
0 |
0 |
33 |
0 |
0 |
1 |
1 |
1 |
0 |
34 |
0 |
0 |
0 |
0 |
1 |
1 |
35 |
0 |
0 |
0 |
0 |
0 |
0 |
36 |
0 |
0 |
1 |
0 |
0 |
0 |
Test Animals |
||||||
1 |
0 |
0 |
2 |
1 |
0 |
0 |
2 |
1 |
0 |
2 |
0 |
0 |
0 |
3 |
0 |
1 |
1 |
0 |
0 |
0 |
4 |
1 |
1 |
1 |
1 |
0 |
0 |
5 |
1 |
1 |
1 |
0 |
0 |
0 |
6 |
0 |
1 |
1 |
0 |
0 |
0 |
7 |
1 |
1 |
0 |
0 |
0 |
0 |
8 |
0 |
0 |
1 |
1 |
0 |
0 |
9 |
1 |
1 |
- |
- |
- |
- |
10 |
0 |
0 |
1 |
0 |
0 |
0 |
11 |
0 |
0 |
0 |
0 |
0 |
0 |
12 |
0 |
1 |
2 |
1 |
0 |
0 |
13 |
0 |
0 |
0 |
0 |
0 |
0 |
14 |
0 |
0 |
0 |
0 |
0 |
0 |
15 |
1 |
0 |
0 |
0 |
0 |
0 |
16 |
0 |
1 |
2 |
2 |
1 |
0 |
17 |
0 |
0 |
1 |
1 |
0 |
0 |
18 |
0 |
1 |
2 |
2 |
0 |
0 |
19 |
0 |
1 |
0 |
0 |
0 |
0 |
20 |
1 |
0 |
1 |
1 |
0 |
0 |
One animal died after first exposure. No significant differences in the gain of body weight was observed between treatment and control group.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
